Neose, Novo Nordisk, ratiopharm deal
Neose will sell its assets to existing partners Novo and ratiopharm's BioGeneriX AG subsidiary for a total of about $43 million
Gathering data...
Neose will sell its assets to existing partners Novo and ratiopharm's BioGeneriX AG subsidiary for a total of about $43 million